— PUBLICATIONS —

Liste des publications GINECO - Cancer Ovaire 2013

  • Calypso – Article (Gynecologic Oncology)
    B. You
    The strong prognostic value of KELIM, a model-based parameter from CA 125 kinetics in ovarian cancer: Data from CALYPSO trial (a GINECO-GCIG study).
    Gynecologic Oncology - Août 2013 (réf. PubMed : PMID: 23694718 [PubMed - indexed for MEDLINE])
  • Calypso – Article (Gynecologic Oncology)
    C.K. Lee
    A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer.
    Annals of Oncology - Avril 2013 (réf. PMID: PMID: 23104722 [PubMed - indexed for MEDLINE])
  • FAG3 – Article (Annals of Oncology)
    C. Falandry
    Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial.
    Annals of Oncology - Novembre 2013 (réf. PMID: 24061628 [PubMed - in process])
  • OCTAVIA – Article (European Journal of Cancer)
    A. Gonzalez-Martin
    Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer.
    European Journal of Cancer - Septembre 2013 (réf. PMID: 24007819 [PubMed - as supplied by publisher])
  • ETAMINE – Article (Support Care Cancer)
    B. Weber
    A potentially neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trial.
    Support Care Cancer - Juillet 2013 (réf. PubMed : PMID: 23420555 [PubMed - in process])
  • ICON7 – Article (The Lancet Oncology)
    D. Stark
    Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial
    The Lancet Oncology - Mars 2013 (réf. PubMed : PMID: 23333117 [PubMed - in process])
  • MIMOSA – Article (Journal of Clinical Oncology)
    P. Sabbatini
    Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--the MIMOSA study.
    Journal of Clinical Oncology - Avril 2013 Apr (réf. PubMed : PMID: 23478059 [PubMed - indexed for MEDLINE])
  • Analysis of prospective – Article (Journal of Clinical Oncology)
    S. Mahner
    Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trials.
    European Journal of Cancer - Janvier 2013 (réf. PubMed : PMID: 22921185 [PubMed - indexed for MEDLINE])

Haut de page

Modifié le 30-08-2016 16:08